EyeBio is a company developing a new generation of therapies to protect, restore, and improve vision.
peer of
investor of
competitor of
Metrics
marketPRIVATE
msh_idCOM:EYEBIOTECH
websitehttps://eyebiotech.com
source_ref47a71c42-cfca-4c2c-a988-62523a10ff61
company_size11
products_or_servicesNovel therapies for eye diseases, including Restoret for diabetic macular edema and neovascular age-related macular degeneration, and a preclinical pipeline targeting retinal diseases.